Industry News
Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy
Mar 21, 2012
Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with tyrosine kinase inhibitors (TKI)... Read More
Using Molecular Analysis To Identify Specific Cancers
Mar 21, 2012
Researchers from Huntsman Cancer Institute (HCI) at the University of Utah report they have discovered a method to identify cancer-causing rearrangements of genetic material called chromosomal translocations quickly, accurately, and inexpensively. A description of the method and the research results appear online in this month's issue of the EMBO Molecular Medicine journal... Read More
Two Cancer-Promoting Pathways Linked In Esophageal Cancer
Mar 21, 2012
Identification of a non-traditional pathway for spiriting a cancer-promoting protein into the cell nucleus points to a possible combination therapy for esophageal cancer and indicates a mechanism of resistance for new drugs that attack the Hedgehog pathway... Read More
Researchers Prepare Clinical Trial That Will Use Fat-Enclosed Nanoparticles To Accurately Irradiate Brain Tumors
Mar 21, 2012
For the past 40 years, radiation has been the most effective method for treating deadly brain tumors called glioblastomas. But, although the targeting technology has been refined, beams of radiation still must pass through healthy brain tissue to reach the tumor, and patients can only tolerate small amounts before developing serious side effects... Read More
Researchers Building Melanoma Vaccine To Combat Skin Cancer
Mar 21, 2012
Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, uses a genetically engineered version of the vesicular stomatitis virus to deliver a broad spectrum of genes derived from melanoma cancer cells directly into tumors... Read More
Novel Therapy Discovered For Crohn's Disease
Mar 21, 2012
The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn's disease, a form of inflammatory bowel disease (IBD). CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties... Read More
New Method To Test A Tumor's Resistance To An Experimental Therapy
Mar 21, 2012
Drug resistance is a serious problem for cancer patients - over time, a therapy that was once providing some benefit simply stops working. Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) recently discovered how cancer cells develop resistance to a drug called MLN4924... Read More
Publication Of Cytori Breast Reconstruction Cell Therapy Trial Results
Mar 21, 2012
Cytori Therapeutics (NASDAQ: CYTX) has announced the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology. RESTORE-2 is a 71 patient multi-center, prospective clinical trial using autologous adipose-derived regenerative cell (ADRC)-enriched fat grafting for reconstruction of the breast after cancer surgery... Read More
Improved Understanding Of Blood Clotting
Mar 21, 2012
How and when our blood clots is one of those incredibly complex and important processes in our body that we rarely think about. If your blood doesn't clot and you cut yourself, you could bleed to death, if your blood clots too much, you could be in line for a heart attack or stroke. Dr... Read More
Votrient (Pazopanib) Gets FDA Panel Green Light For Advanced Soft Tissue Sarcoma Treatment
Mar 20, 2012
The FDA's Oncologic Drugs Advisory Committee (ODAC) has recommended the approval of Votrient (pazopanib) for the treatment of the rare cancer advanced soft tissue sarcoma. Patients who were already administered chemotherapy will be eligible for pazopanib if the FDA (Food and Drug Administration) goes along with the Committee's recommendation... Read More
Previous Page Next Page